CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Mylan Pharmaceuticals Inc recalls Acamprosate Calcium

Read the official FDA notice

Published
26 Aug 2026
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.

Brand / company
Mylan Pharmaceuticals Inc
Codes / lots
Lot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 26 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.